We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Discordant Results From Reverse Sequence Syphilis Screening-- Five Laboratories, United States, 2006-2010.
- Authors
Radolf, J. D.; Bolan, G.; Park, I. U.; Chow, J. M.; Schillinger, J. A.; Pathela, P.; Blank, S.; Zanto, S. N.; Hoover, K. W.; Workowski, K. A.; Cox, D. L.; Ballard, R. C.
- Abstract
The article describes the results of an analysis conducted by the U.S. Centers for Disease Control and Prevention (CDC) of data from several laboratories that used reverse sequence screening for syphilis from 2006 to 2010. It was found that 56.7 percent had a nonreactive rapid plasma reagin (RPR) test among serareactive on initial screening with a treponemal automatable treponemal enzyme and chemiluminescence immunoassays (EIA/CIA). A CDC editorial note on the analysis is presented recommending the use of nontreponemal tests to screen for syphilis. INSET: What is already known on this topic?.
- Subjects
UNITED States; MEDICAL screening; CENTERS for Disease Control &; Prevention (U.S.); DIAGNOSIS of syphilis; SEXUALLY transmitted disease diagnosis; CHEMILUMINESCENCE immunoassay; TREPONEMATOSES
- Publication
JAMA: Journal of the American Medical Association, 2011, Vol 305, Issue 12, p1189
- ISSN
0098-7484
- Publication type
Article